Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

37P - Obesity and ovarian cancer, a controversial risk factor

Date

17 Jun 2022

Session

Poster Display session

Topics

Tumour Site

Ovarian Cancer

Presenters

Firas Baidoun

Citation

Annals of Oncology (2022) 33 (suppl_5): S395-S401. 10.1016/annonc/annonc918

Authors

F. Baidoun1, J. Abdeldayem2, A.M. Saad3, M.T. Sarmini1, M.M. Gad1, M. Alhaj Moustafa4

Author affiliations

  • 1 Cleveland Clinic, Cleveland/US
  • 2 Case Western Reserve, University Hospitals, Cleveland/US
  • 3 Wayne State University, Detroit/US
  • 4 Mayo Clinic-Florida, Jacksonville/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 37P

Background

Ovarian cancer is the eighth most common malignancy in females and the third most common gynaecological malignancy in the world. It is the leading cause of gynaecological cancer death in the world. Obesity, which is increasing worldwide, is still a controversial risk factor for ovarian cancer and till now there is no consensus on the obesity role on ovarian cancer. Therefore, we investigated the association between obesity and ovarian cancer using a large inpatient database.

Methods

We used the National Inpatient Sample (NIS) database to review female admissions between 2002 and 2015. Patients were grouped based on the presence or absence of obesity using the appropriate ICD-9 codes. We used a multivariate logistic regression to assess the association between obesity and ovarian cancer.

Results

We reviewed 50,469,770 admissions of which 4,365,971 (8.7%) were obese. Both groups had a similar median age (54 years) but obese patients were more likely to be black (20% vs. 14%, P<.001), have polycystic ovarian syndrome (PCOS) (0.5% vs 0.1%, P<.001), endometriosis (0.9% vs. 0.7%, P<.001) and be smokers (12% vs 9%, P<.001). Family history of ovarian cancer was similar in both groups. After adjusting for age, BRCA1/BRCA2 mutations, family history, lynch syndrome, smoking, IUD, endometriosis, PCOS, infertility, oral contraceptive pills, and hormone replacement therapy, obese patients were significantly less likely to have ovarian cancer (OR=0.821, 95%CI[0.808-0.835], P< .001) compared with patients without obesity. To further assess the association between obesity and ovarian cancer in pre-menopause vs post-menopause, we did a subgroup analysis based on age, the same trend was observed in both patients younger and older than 50 years.

Conclusions

In our large database study, we found that obesity was associated with lower rate of ovarian cancer and that association was seen in both young and older patients. However, the timeliness of obesity in relation to ovarian cancer cannot be determined through the NIS database and thus further prospective epidemiological studies are warranted.

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.